Volume 24, Issue 4 - Writing for Lay Audiences

Package leaflets for medication in the EU: The possibility of integrating patients’ perspectives in a regulated genre?

Author: Antoinette Fage-Butler

Abstract

Download the full article

References

1. Leventhal P. Writing matters. Medical Writing. 2012;21(3):191–2.
2. Fage-Butler AM. Towards a new kind of patient information leaflet? Risk, trust and the value of patient centeredness [PhD]. Aarhus: Aarhus University; 2011.
3. Raynor DK, Blenkinsopp A, Knapp P, Grime J, Nicolson DJ, Pollock K, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):i–180.
4. Björnsdóttir I, Almarsdóttir AB, Traulsen JM. The lay public's explicit and implicit definitions of drugs. Res Social Adm Pharm. 2009;5(1):40–50.
5. Raynor DK, Savage I, Knapp P, Henley J. We are the experts: people with asthma talk about their medicine information needs. Patient Educ Couns. 2004;53(2):167–74.
6. Kain DJ. Constructing genre: A threefold typology. Tech Comm Q. 2005;14(4):375–409.
7. European Medicines Agency. Quality Review of Documents human product-information annotated template (English) version 9.1; 2015. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2009/10/WC500004368.pdfhttp://
8. Pander Maat H, Lentz L. Using sorting data to evaluate text structure: an evidence-based proposal for restructuring patient information leaflets. Technical Communication. 2011;58(3):197–216.
9. Raynor DK. Commentary: Readability testing of patient leaflets – where to now? Scrip World Pharmaceutical News. 2008;3328:7.
10. Medicines and Healthcare Products Regulatory Agency. Best practice guidance on patient information leaflets; 2012. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/328405/Best_practice_guidance_on_patient_information_leaflets.pdf
11. Berkenkotter C. Understanding a writer's awareness of audience. Coll Compos Commun. 1981;32(4):388–99.
12. Foucault M. The archaeology of knowledge. New York: Pantheon; 1972.
13. European Commission. Directive 2001/83/EC of the European Parliament and of the Council. Brussels: The European Parliament and the Council of the European Union; 2001.
14. European Commission. Guideline on the readability of the labelling and package leaflet of medicinal products for human use, Revision 1, 12 January 2009 Brussels: European Commission; 2009. Available from: http://ec.europa.eu/health/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf
15. Cutts M. Making leaflets clearer for patients. Medical Writing. 2015;24(1):14–9.
16. Ferguson T. E-patients: How they can help us heal health care. White paper. E-patients Scholars Working Group, San Francisco, CA; 2007. p. 126. Available from: http://e-patients.net/e-Patients_White_Paper.pdf
17. Morse JM. Towards a praxis theory of suffering. Adv Nurs Sci. 2001;24(1):47–59.
18. Berry DC, Michas IC, Bersellini E. Communicating information about medication: the benefits of making it personal. Psychol Health. 2003;18(1):127–39.
19. Billiones R. Document templates for medical writers. Medical Writing. 2014;23(1):17–21.
20. Pander Maat H, Lentz L. Improving the usability of patient information leaflets. Patient Educ Couns. 2010;80(1):113–9.
21. European Medicines Agency. Patients and carers; 2015. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/audience/alp_audiencetype_000001.jsp&mid=
22. Lang S, Esser M. Improving patient communication by writing with empathy. Medical Writing. 2012;21(4):305–7.
23. van der Waarde K. Measuring the quality of information in medical package leaflets: harmful or helpful? Information Design Journal. 2008;16(3):216–28.